Bob Siegerink

Bob Siegerink

Auto-generated profile, based on publicly available information

Bob Siegerink

Department of Clinical Epidemiology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2020 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
FKFrederikus A. Klok
Frederikus A. Klok
GBGudula J.A.M. Boon
Gudula J.A.M. Boon
SBStefano Barco
Stefano Barco
MEMatthias Endres
Matthias Endres
JGJ.J. Miranda Geelhoed
J.J. Miranda Geelhoed
BSBob Siegerink
Bob Siegerink
We propose an ordinal tool to measure the full spectrum of functional outcomes following COVID-19. This “Post-COVID-19 Functional Status (PCFS) Scale” can be used for tracking functional status over time as well as for research purposes.

1 November 2009 in The Lancet Neurology
Verified
Journal Article
Closed access
RURolf T Urbanus
Rolf T Urbanus
BSBob Siegerink
Bob Siegerink
MRMark Roest
Mark Roest
FRFrits R Rosendaal
Frits R Rosendaal
PGPhilip G de Groot
Philip G de Groot
AAAle Algra
Ale Algra

1 July 2017 in Stroke
Verified
Journal Article
Closed access
AAAnnette Aigner
Annette Aigner
UGUlrike Grittner
Ulrike Grittner
ARArndt Rolfs
Arndt Rolfs
BNBo Norrving
Bo Norrving
BSBob Siegerink
Bob Siegerink
MBMarkus A. Busch
Markus A. Busch
Background and Purpose—: As stroke in young adults is assumed to have different etiologies and risk factors than in older populations, the aim of this study was to examine the contribution of established potentially modifiable cardiovascular risk factors to the burden of stroke in young adults. Methods—: A German nationwide case–control study based on patients enrolled in the SIFAP1 study (Stroke In Young Fabry Patients) 2007 to 2010 and controls from the population-based GEDA study (German Health Update) 2009 to 2010 was performed. Cases were 2125 consecutive patients aged 18 to 55 years with acute first-ever stroke from 26 clinical stroke centers; controls (age- and sex-matched, n=8500, without previous stroke) were from a nationwide community sample. Adjusted population-attributable risks of 8 risk factors (hypertension, hyperlipidemia, diabetes mellitus, coronary heart disease, smoking, heavy episodic alcohol consumption, low physical activity, and obesity) and their combinations for all stroke, ischemic stroke, and primary intracerebral hemorrhage were calculated. Results—: Low physical activity and hypertension were the most important risk factors, accounting for 59.7% (95% confidence interval, 56.3–63.2) and 27.1% (95% confidence interval, 23.6–30.6) of all strokes, respectively. All 8 risk factors combined explained 78.9% (95% confidence interval, 76.3–81.4) of all strokes. Population-attributable risks of all risk factors were similar for all ischemic stroke subtypes. Population-attributable risks of most risk factors were higher in older age groups and in men. Conclusions—: Modifiable risk factors previously established in older populations also account for a large part of stroke in younger adults, with 4 risk factors explaining almost 80% of stroke risk. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00414583.

16 October 2014 in Nephrology Dialysis Transplantation
Verified
Journal Article
Closed access
MSMarit M. Suttorp
Marit M. Suttorp
BSBob Siegerink
Bob Siegerink
KJKitty J. Jager
Kitty J. Jager
CZCarmine Zoccali
Carmine Zoccali
FDFriedo W. Dekker
Friedo W. Dekker
Since confounding obscures the real effect of the exposure, it is important to adequately address confounding for making valid causal inferences from observational data. Directed acyclic graphs (DAGs) are visual representations of causal assumptions that are increasingly used in modern epidemiology. They can help to identify the presence of confounding for the causal question at hand. This structured approach serves as a visual aid in the scientific discussion by making underlying relations explicit. This article explains the basic concepts of DAGs and provides examples in the field of nephrology with and without presence of confounding. Ultimately, these examples will show that DAGs can be preferable to the traditional methods to identify sources of confounding, especially in complex research questions.

1 October 2015 in Atherosclerosis
Verified
Journal Article
Closed access
ANAlexander H. Nave
Alexander H. Nave
KLKristin S. Lange
Kristin S. Lange
CLChristopher O. Leonards
Christopher O. Leonards
BSBob Siegerink
Bob Siegerink
WDWolfram Doehner
Wolfram Doehner
MEMartin Ebinger
Martin Ebinger

26 February 2010 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
MVMarion Verduijn
Marion Verduijn
BSBob Siegerink
Bob Siegerink
KJKitty J. Jager
Kitty J. Jager
carmine zoccalicarmine zoccali
carmine zoccali
FDFriedo W. Dekker
Friedo W. Dekker
The aim of aetiologic studies in epidemiology is to investigate whether factors are causally related to diseases and therefore become a potential target for therapeutic interventions. Mendelian randomization enables estimation of causal relationships in observational studies using genetic variants as instrumental variables. An instrumental variable is a variable that can be considered to mimic the coin toss in a randomized study. Given the random assignment of alleles in gamete formation, the use of genetic variants is an alternative method to control for confounding. This educational article describes the approach of Mendelian randomization, its underlying rationale and its necessary assumptions.